119 related articles for article (PubMed ID: 24529874)
1. Hormones and cardiovascular disease in older men.
Yeap BB; Flicker L
J Am Med Dir Assoc; 2014 May; 15(5):326-33. PubMed ID: 24529874
[TBL] [Abstract][Full Text] [Related]
2. Hormones and health outcomes in aging men.
Yeap BB
Exp Gerontol; 2013 Jul; 48(7):677-81. PubMed ID: 22884846
[TBL] [Abstract][Full Text] [Related]
3. Androgens and cardiovascular disease.
Yeap BB
Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
[TBL] [Abstract][Full Text] [Related]
4. In older men, higher plasma testosterone or dihydrotestosterone is an independent predictor for reduced incidence of stroke but not myocardial infarction.
Yeap BB; Alfonso H; Chubb SA; Hankey GJ; Handelsman DJ; Golledge J; Almeida OP; Flicker L; Norman PE
J Clin Endocrinol Metab; 2014 Dec; 99(12):4565-73. PubMed ID: 25268392
[TBL] [Abstract][Full Text] [Related]
5. Sex steroids and cardiovascular disease.
Yeap BB
Asian J Androl; 2014; 16(2):239-47. PubMed ID: 24407188
[TBL] [Abstract][Full Text] [Related]
6. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.
Rodondi N; Newman AB; Vittinghoff E; de Rekeneire N; Satterfield S; Harris TB; Bauer DC
Arch Intern Med; 2005 Nov; 165(21):2460-6. PubMed ID: 16314541
[TBL] [Abstract][Full Text] [Related]
7. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
[TBL] [Abstract][Full Text] [Related]
8. Differential associations of testosterone, dihydrotestosterone and oestradiol with physical, metabolic and health-related factors in community-dwelling men aged 17-97 years from the Busselton Health Survey.
Yeap BB; Knuiman MW; Divitini ML; Handelsman DJ; Beilby JP; Beilin J; McQuillan B; Hung J
Clin Endocrinol (Oxf); 2014 Jul; 81(1):100-8. PubMed ID: 24428256
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
Jones TH; Kelly DM
Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
[TBL] [Abstract][Full Text] [Related]
10. Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men.
Friedrich N; Schneider HJ; Haring R; Nauck M; Völzke H; Kroemer HK; Dörr M; Klotsche J; Jung-Sievers C; Pittrow D; Lehnert H; März W; Pieper L; Wittchen HU; Wallaschofski H; Stalla GK
Steroids; 2012 Jan; 77(1-2):52-8. PubMed ID: 22037276
[TBL] [Abstract][Full Text] [Related]
11. Testosterone and cardiovascular disease risk.
Yeap BB
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):193-202. PubMed ID: 25887389
[TBL] [Abstract][Full Text] [Related]
12. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.
Yeap BB
Asian J Androl; 2018; 20(2):109-114. PubMed ID: 29199649
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risk factors and prevention in women: similarities and differences].
Sclavo M
Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and cardiovascular risk in men.
Kelly DM; Jones TH
Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
[TBL] [Abstract][Full Text] [Related]
15. Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years.
Chan YX; Knuiman MW; Hung J; Divitini ML; Beilby JP; Handelsman DJ; Beilin J; McQuillan B; Yeap BB
Clin Endocrinol (Oxf); 2016 Oct; 85(4):575-82. PubMed ID: 27106765
[TBL] [Abstract][Full Text] [Related]
16. Are declining testosterone levels a major risk factor for ill-health in aging men?
Yeap BB
Int J Impot Res; 2009; 21(1):24-36. PubMed ID: 19037223
[TBL] [Abstract][Full Text] [Related]
17. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
18. Testosterone therapy and cardiovascular risk: advances and controversies.
Morgentaler A; Miner MM; Caliber M; Guay AT; Khera M; Traish AM
Mayo Clin Proc; 2015 Feb; 90(2):224-51. PubMed ID: 25636998
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
Akin F; Yaylali GF; Turgut S; Kaptanoglu B
Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
